{"transactions":[{"id":710256,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":132714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Immediately prior to the Effective Time, pursuant to the Merger Agreement, each outstanding performance stock unit award (\"PSU\") automatically converted into and was substituted with a restricted stock unit award (each, a \"Converted PSU\") with respect to a number of Shares equal to either (x) for each PSU granted on or after March 1, 2026, the excess of (A) 100% of the \"Target Shares\" (as the term \"Target Shares\" is defined and set forth in the applicable award agreement governing such PSU) underlying such PSU over (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved, or (y) for each PSU granted prior to March 1, 2026, the excess of (A) the percentage of the \"Target Shares\" underlying such PSU as to which the \"Performance-Requirement\" would be satisfied if the \"Closing Price\" (as defined in the applicable award agreement governing such PSU) were equal to the Closing Amount over"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"(Continued from footnote 7) (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved. Immediately prior to the Effective Time, each Converted PSU was automatically cancelled and converted into the right to receive (A) an amount in cash, without interest, and subject to deduction for any required tax withholding, equal to the product of (i) the number of Shares subject to such Converted PSU and (ii) the Closing Amount, and (B) one CVR for each Share subject to such Converted PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Immediately prior to the Effective Time, pursuant to the Merger Agreement, each outstanding performance stock unit award (\"PSU\") automatically converted into and was substituted with a restricted stock unit award (each, a \"Converted PSU\") with respect to a number of Shares equal to either (x) for each PSU granted on or after March 1, 2026, the excess of (A) 100% of the \"Target Shares\" (as the term \"Target Shares\" is defined and set forth in the applicable award agreement governing such PSU) underlying such PSU over (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved, or (y) for each PSU granted prior to March 1, 2026, the excess of (A) the percentage of the \"Target Shares\" underlying such PSU as to which the \"Performance-Requirement\" would be satisfied if the \"Closing Price\" (as defined in the applicable award agreement governing such PSU) were equal to the Closing Amount over"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"(Continued from footnote 7) (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved. Immediately prior to the Effective Time, each Converted PSU was automatically cancelled and converted into the right to receive (A) an amount in cash, without interest, and subject to deduction for any required tax withholding, equal to the product of (i) the number of Shares subject to such Converted PSU and (ii) the Closing Amount, and (B) one CVR for each Share subject to such Converted PSU."}],"balance_after":0,"derivative":{"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":132714},"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":710255,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":116245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Immediately prior to the Effective Time, pursuant to the Merger Agreement, each outstanding performance stock unit award (\"PSU\") automatically converted into and was substituted with a restricted stock unit award (each, a \"Converted PSU\") with respect to a number of Shares equal to either (x) for each PSU granted on or after March 1, 2026, the excess of (A) 100% of the \"Target Shares\" (as the term \"Target Shares\" is defined and set forth in the applicable award agreement governing such PSU) underlying such PSU over (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved, or (y) for each PSU granted prior to March 1, 2026, the excess of (A) the percentage of the \"Target Shares\" underlying such PSU as to which the \"Performance-Requirement\" would be satisfied if the \"Closing Price\" (as defined in the applicable award agreement governing such PSU) were equal to the Closing Amount over"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"(Continued from footnote 7) (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved. Immediately prior to the Effective Time, each Converted PSU was automatically cancelled and converted into the right to receive (A) an amount in cash, without interest, and subject to deduction for any required tax withholding, equal to the product of (i) the number of Shares subject to such Converted PSU and (ii) the Closing Amount, and (B) one CVR for each Share subject to such Converted PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Immediately prior to the Effective Time, pursuant to the Merger Agreement, each outstanding performance stock unit award (\"PSU\") automatically converted into and was substituted with a restricted stock unit award (each, a \"Converted PSU\") with respect to a number of Shares equal to either (x) for each PSU granted on or after March 1, 2026, the excess of (A) 100% of the \"Target Shares\" (as the term \"Target Shares\" is defined and set forth in the applicable award agreement governing such PSU) underlying such PSU over (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved, or (y) for each PSU granted prior to March 1, 2026, the excess of (A) the percentage of the \"Target Shares\" underlying such PSU as to which the \"Performance-Requirement\" would be satisfied if the \"Closing Price\" (as defined in the applicable award agreement governing such PSU) were equal to the Closing Amount over"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"(Continued from footnote 7) (B) the number of \"Target Shares\" as to which, as of immediately prior to the Effective Time, the \"Performance-Requirement\" has been achieved. Immediately prior to the Effective Time, each Converted PSU was automatically cancelled and converted into the right to receive (A) an amount in cash, without interest, and subject to deduction for any required tax withholding, equal to the product of (i) the number of Shares subject to such Converted PSU and (ii) the Closing Amount, and (B) one CVR for each Share subject to such Converted PSU."}],"balance_after":0,"derivative":{"expiration_date":"2029-03-11","underlying":"Common Stock","underlying_shares":116245},"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":710254,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, a \"Company Stock Option\") that had an exercise price per Share that was less than the sum of the Closing Amount and the fair market value of one CVR (each, a \"Terminating Company Stock Option\") became fully vested and was cancelled, and in exchange therefor, the holder received (i) an amount in cash, without interest, and subject to deduction for any required withholding taxes, equal to the product of (A) the excess of the Closing Amount over the exercise price per Share with respect to such Terminating Company Stock Option and (B) the number of Shares subject to such Terminating Company Stock Option, plus (ii) one CVR with respect to each Share subject to such Terminating Company Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"As of immediately prior to the Effective Time, each Company Stock Option that did not constitute a Terminating Company Stock Option was cancelled and no consideration was delivered in exchange therefor."}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":710253,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, a \"Company Stock Option\") that had an exercise price per Share that was less than the sum of the Closing Amount and the fair market value of one CVR (each, a \"Terminating Company Stock Option\") became fully vested and was cancelled, and in exchange therefor, the holder received (i) an amount in cash, without interest, and subject to deduction for any required withholding taxes, equal to the product of (A) the excess of the Closing Amount over the exercise price per Share with respect to such Terminating Company Stock Option and (B) the number of Shares subject to such Terminating Company Stock Option, plus (ii) one CVR with respect to each Share subject to such Terminating Company Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"As of immediately prior to the Effective Time, each Company Stock Option that did not constitute a Terminating Company Stock Option was cancelled and no consideration was delivered in exchange therefor."}],"balance_after":0,"derivative":{"exercise_price":18.66,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":710252,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Depositary Shares - 8.375% Series B Cumulative Stock","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":102000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Prior to the Effective Time, pursuant to the Merger Agreement, each issued and outstanding share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share, of the Issuer (including the Depositary Shares) was redeemed by the Issuer in accordance with the terms of the certificate of designation governing such stock, including payment of all accrued and unpaid dividends thereon through the date of such redemption."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Prior to the Effective Time, pursuant to the Merger Agreement, each issued and outstanding share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share, of the Issuer (including the Depositary Shares) was redeemed by the Issuer in accordance with the terms of the certificate of designation governing such stock, including payment of all accrued and unpaid dividends thereon through the date of such redemption."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":710251,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"other","planned":false,"acquired":false,"shares":752,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the time the Merger became effective (the \"Effective Time\"), pursuant to the Merger Agreement, each issued and outstanding share of common stock, par value $0.0075 per share, of the Issuer (the \"Shares\") (other than certain Shares cancelled pursuant to the Merger Agreement and Dissenting Shares (as defined in the Merger Agreement)) automatically converted into the right to receive (i) $39.00 per Share in cash, without interest, and subject to deduction for any required withholding tax (the \"Closing Amount\"), plus (ii) an amount of contingent value rights (each, a \"CVR\") representing a right to receive certain contingent payments subject to and in accordance with the terms of the CVR Agreement (as defined in the Merger Agreement) (the Closing Amount plus CVR, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the time the Merger became effective (the \"Effective Time\"), pursuant to the Merger Agreement, each issued and outstanding share of common stock, par value $0.0075 per share, of the Issuer (the \"Shares\") (other than certain Shares cancelled pursuant to the Merger Agreement and Dissenting Shares (as defined in the Merger Agreement)) automatically converted into the right to receive (i) $39.00 per Share in cash, without interest, and subject to deduction for any required withholding tax (the \"Closing Amount\"), plus (ii) an amount of contingent value rights (each, a \"CVR\") representing a right to receive certain contingent payments subject to and in accordance with the terms of the CVR Agreement (as defined in the Merger Agreement) (the Closing Amount plus CVR, the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":710250,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-15T01:45:13.000Z","date":"2026-07-14","kind":"other","planned":false,"acquired":false,"shares":191264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the time the Merger became effective (the \"Effective Time\"), pursuant to the Merger Agreement, each issued and outstanding share of common stock, par value $0.0075 per share, of the Issuer (the \"Shares\") (other than certain Shares cancelled pursuant to the Merger Agreement and Dissenting Shares (as defined in the Merger Agreement)) automatically converted into the right to receive (i) $39.00 per Share in cash, without interest, and subject to deduction for any required withholding tax (the \"Closing Amount\"), plus (ii) an amount of contingent value rights (each, a \"CVR\") representing a right to receive certain contingent payments subject to and in accordance with the terms of the CVR Agreement (as defined in the Merger Agreement) (the Closing Amount plus CVR, the \"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"At the Effective Time, pursuant to the Merger Agreement, each outstanding restricted stock unit (\"RSU\") became fully vested and cancelled and converted into the right to receive (A) an amount in cash, without interest, and subject to deduction for any required withholding tax, equal to the product of (i) the number of Shares subject to such RSU and (ii) the Closing Amount, plus (B) one CVR for each Share subject to such RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated April 27, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger on May 16, 2026 (as amended, the \"Merger Agreement\"), by and among XOMA Royalty Corporation (the \"Issuer\"), Ligand Pharmaceuticals Incorporated (\"Parent\"), Flex Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), and XOMA Royalty Holdings Corporation (\"HoldCo\"). Pursuant to the Merger Agreement, on July 14, 2026, the Issuer effected a holding company reorganization, and Merger Sub merged with and into HoldCo (the \"Merger\"), with HoldCo surviving the Merger as a wholly-owned subsidiary of Parent. Unless context otherwise requires, all references in this Form 4 to the \"Issuer\" refer to HoldCo, which assumed all obligations of the Issuer under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the time the Merger became effective (the \"Effective Time\"), pursuant to the Merger Agreement, each issued and outstanding share of common stock, par value $0.0075 per share, of the Issuer (the \"Shares\") (other than certain Shares cancelled pursuant to the Merger Agreement and Dissenting Shares (as defined in the Merger Agreement)) automatically converted into the right to receive (i) $39.00 per Share in cash, without interest, and subject to deduction for any required withholding tax (the \"Closing Amount\"), plus (ii) an amount of contingent value rights (each, a \"CVR\") representing a right to receive certain contingent payments subject to and in accordance with the terms of the CVR Agreement (as defined in the Merger Agreement) (the Closing Amount plus CVR, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, pursuant to the Merger Agreement, each outstanding restricted stock unit (\"RSU\") became fully vested and cancelled and converted into the right to receive (A) an amount in cash, without interest, and subject to deduction for any required withholding tax, equal to the product of (i) the number of Shares subject to such RSU and (ii) the Closing Amount, plus (B) one CVR for each Share subject to such RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-303725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526303725/ownership.xml","form_type":"4"}},{"id":725453,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-27T00:33:06.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000673","document":"wk-form4_1782520384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000147083126000673/wk-form4_1782520384.xml","form_type":"4"}},{"id":780797,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-13T21:50:16.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the RSUs shall vest on May 11, 2027 and 1/3 of the RSUs shall vest in equal annual installments until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the RSUs shall vest on May 11, 2027 and 1/3 of the RSUs shall vest in equal annual installments until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001575933-26-000002","document":"form4-05132026_090512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000157593326000002/form4-05132026_090512.xml","form_type":"4"}},{"id":803385,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-22T20:30:09.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":10568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":116245,"derivative":{"expiration_date":"2029-03-11","underlying":"Common Stock","underlying_shares":10568},"source":{"system":"sec-edgar","filing":"0001214659-26-004969","document":"marketforms-72957.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465926004969/marketforms-72957.xml","form_type":"4"}},{"id":803384,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-22T20:30:09.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":10568,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191264,"source":{"system":"sec-edgar","filing":"0001214659-26-004969","document":"marketforms-72957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465926004969/marketforms-72957.xml","form_type":"4"}},{"id":840075,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-17T20:38:26.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":126813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":126813,"derivative":{"underlying":"Common Stock","underlying_shares":126813},"source":{"system":"sec-edgar","filing":"0001214659-26-003399","document":"marketforms-72595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465926003399/marketforms-72595.xml","form_type":"4"}},{"id":840074,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:38:26.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":82428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units payable solely in common stock that will vest as to 25% on each of the first four anniversaries of March 11, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":180696,"source":{"system":"sec-edgar","filing":"0001214659-26-003399","document":"marketforms-72595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465926003399/marketforms-72595.xml","form_type":"4"}},{"id":978347,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Depositary Shares - 8.375% B Cumulative Stock","published_at":"2025-12-08T21:30:18.000Z","date":"2025-12-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":25.05,"value":2505000.0,"ownership":{"direct":true},"balance_after":102000,"source":{"system":"sec-edgar","filing":"0001214659-25-017720","document":"marketforms-71439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465925017720/marketforms-71439.xml","form_type":"4"}},{"id":1034066,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2025-09-23T21:32:38.000Z","date":"2025-09-19","kind":"exercise","planned":false,"acquired":false,"shares":35567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share."}],"balance_after":132714,"derivative":{"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":35567},"source":{"system":"sec-edgar","filing":"0001214659-25-014068","document":"marketforms-70452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465925014068/marketforms-70452.xml","form_type":"4"}},{"id":1034065,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-23T21:32:38.000Z","date":"2025-09-19","kind":"exercise","planned":false,"acquired":true,"shares":35567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98268,"source":{"system":"sec-edgar","filing":"0001214659-25-014068","document":"marketforms-70452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465925014068/marketforms-70452.xml","form_type":"4"}},{"id":1104987,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:50.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000048","document":"wk-form4_1750450303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000166257925000048/wk-form4_1750450303.xml","form_type":"4"}},{"id":1139696,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2025-05-21T23:11:24.000Z","date":"2025-05-19","kind":"exercise","planned":false,"acquired":false,"shares":53359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each PSU represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share."}],"balance_after":168281,"derivative":{"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":53359},"source":{"system":"sec-edgar","filing":"0001214659-25-008201","document":"marketforms-69618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465925008201/marketforms-69618.xml","form_type":"4"}},{"id":1139695,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-21T23:11:24.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":25637,"price":25.38,"value":650667.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax withholding obligations incurred upon settlement of the Performance Stock Units (\"PSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price of the shares.  The shares were sold in multiple transactions at prices ranging from $25.34 to $25.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":62701,"source":{"system":"sec-edgar","filing":"0001214659-25-008201","document":"marketforms-69618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465925008201/marketforms-69618.xml","form_type":"4"}},{"id":1139694,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-21T23:11:24.000Z","date":"2025-05-19","kind":"exercise","planned":false,"acquired":true,"shares":53359,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":88338,"source":{"system":"sec-edgar","filing":"0001214659-25-008201","document":"marketforms-69618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465925008201/marketforms-69618.xml","form_type":"4"}},{"id":1367723,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2024-11-13T23:55:07.000Z","date":"2024-11-11","kind":"exercise","planned":false,"acquired":false,"shares":53360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each PSU represents a contingent right to receive one share of the Issuer's common stock (the \"Common Stock\").  The PSUs vest upon the Common Stock achieving a specified price per share."}],"balance_after":221640,"derivative":{"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":53360},"source":{"system":"sec-edgar","filing":"0001214659-24-018899","document":"marketforms-67329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465924018899/marketforms-67329.xml","form_type":"4"}},{"id":1367722,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-13T23:55:07.000Z","date":"2024-11-13","kind":"sale","planned":false,"acquired":false,"shares":21881,"price":29.95,"value":655335.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax withholding obligations incurred upon settlement of the Performance Stock Units (\"PSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price of the shares.  The shares were sold in multiple transactions at prices ranging from $29.93 to $30.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":34979,"source":{"system":"sec-edgar","filing":"0001214659-24-018899","document":"marketforms-67329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465924018899/marketforms-67329.xml","form_type":"4"}},{"id":1367721,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-13T23:55:07.000Z","date":"2024-11-11","kind":"exercise","planned":false,"acquired":true,"shares":53360,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56860,"source":{"system":"sec-edgar","filing":"0001214659-24-018899","document":"marketforms-67329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465924018899/marketforms-67329.xml","form_type":"4"}},{"id":1472002,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T20:09:19.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 20, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":32500,"derivative":{"exercise_price":4.05,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001662579-24-000060","document":"wk-form4_1719000552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000166257924000060/wk-form4_1719000552.xml","form_type":"4"}},{"id":1484868,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T20:15:05.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":17520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director."}],"balance_after":17520,"derivative":{"exercise_price":1.75,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":17520},"source":{"system":"sec-edgar","filing":"0000950170-24-071301","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000095017024071301/ownership.xml","form_type":"4"}},{"id":1682032,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2024-01-10T21:30:14.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of XOMA common stock.  The PSUs vest upon XOMA's common stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of XOMA common stock.  The PSUs vest upon XOMA's common stock achieving a specified price per share."}],"balance_after":275000,"derivative":{"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001214659-24-000574","document":"marketforms-64280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465924000574/marketforms-64280.xml","form_type":"4"}},{"id":1734460,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-20T21:21:34.000Z","date":"2023-11-16","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares underlying this option shall vest and become exercisable on November 16, 2024, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":52000,"derivative":{"exercise_price":1.82,"expiration_date":"2033-11-15","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001662579-23-000114","document":"wk-form4_1700515278.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000166257923000114/wk-form4_1700515278.xml","form_type":"4"}},{"id":1766091,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman and Interim CEO"}}],"security":"Common Stock","published_at":"2023-10-04T20:30:18.000Z","date":"2023-10-02","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":13.83,"value":13830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.80 to $13.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001214659-23-013141","document":"marketforms-62761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923013141/marketforms-62761.xml","form_type":"4"}},{"id":1772962,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman and Interim CEO"}}],"security":"Common Stock","published_at":"2023-09-27T20:30:22.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":2499,"price":14.43,"value":36060.57,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.10 to $14.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001214659-23-012683","document":"marketforms-62711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923012683/marketforms-62711.xml","form_type":"4"}},{"id":1772961,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman and Interim CEO"}}],"security":"Common Stock","published_at":"2023-09-27T20:30:22.000Z","date":"2023-09-25","kind":"purchase","planned":false,"acquired":true,"shares":1,"price":14.65,"value":14.65,"ownership":{"direct":true},"balance_after":1,"source":{"system":"sec-edgar","filing":"0001214659-23-012683","document":"marketforms-62711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923012683/marketforms-62711.xml","form_type":"4"}},{"id":1857188,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T20:30:24.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":17520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 9, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director."}],"balance_after":17520,"derivative":{"exercise_price":6.51,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":17520},"source":{"system":"sec-edgar","filing":"0000899243-23-015448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924323015448/doc4.xml","form_type":"4"}},{"id":1879109,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Depositary Shares - 8.375% B Cumulative Stock","published_at":"2023-05-25T20:30:36.000Z","date":"2023-05-24","kind":"purchase","planned":false,"acquired":true,"shares":1032,"price":23.79,"value":24551.28,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001214659-23-007824","document":"marketforms-61633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923007824/marketforms-61633.xml","form_type":"4"}},{"id":1879108,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Depositary Shares - 8.375% B Cumulative Stock","published_at":"2023-05-25T20:30:36.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":768,"price":23.49,"value":18040.32,"ownership":{"direct":true},"balance_after":968,"source":{"system":"sec-edgar","filing":"0001214659-23-007824","document":"marketforms-61633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923007824/marketforms-61633.xml","form_type":"4"}},{"id":1879107,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Depositary Shares - 8.375% B Cumulative Stock","published_at":"2023-05-25T20:30:36.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":23.33,"value":4666.0,"ownership":{"direct":true},"balance_after":200,"source":{"system":"sec-edgar","filing":"0001214659-23-007824","document":"marketforms-61633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923007824/marketforms-61633.xml","form_type":"4"}},{"id":2064523,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T21:35:19.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to this option shall vest monthly over three years from grant date (01/03/2023)."}],"balance_after":75000,"derivative":{"exercise_price":30,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-23-000274","document":"marketforms-58088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923000274/marketforms-58088.xml","form_type":"4"}},{"id":2064522,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T21:35:19.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this option shall vest in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":100000,"derivative":{"exercise_price":18.66,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-23-000274","document":"marketforms-58088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465923000274/marketforms-58088.xml","form_type":"4"}},{"id":2081611,"issuer":{"id":7139,"kind":"organization","name":"ImageneBio, Inc."},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-19T22:21:17.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":35040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal installments on the first, second, and third anniversaries of the grant date."}],"balance_after":35040,"derivative":{"exercise_price":2.62,"expiration_date":"2032-12-15","underlying":"Common Stock","underlying_shares":35040},"source":{"system":"sec-edgar","filing":"0000899243-22-039020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924322039020/doc4.xml","form_type":"4"}},{"id":2185628,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T20:19:43.000Z","date":"2022-08-15","kind":"disposition_to_issuer","acquired":false,"shares":32894,"price":2,"value":65788.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":8,"expiration_date":"2024-06-04","underlying":"Common Stock","underlying_shares":32894},"source":{"system":"sec-edgar","filing":"0000899243-22-028649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924322028649/doc4.xml","form_type":"4"}},{"id":2185627,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T20:19:43.000Z","date":"2022-08-15","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":3.6,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options automatically vested and were cancelled, by virtue of the Merger and without any action on the part of the Reporting Person, and the Reporting Person was entitled to receive (without interest) (A) an amount in cash (less applicable Tax withholdings) equal to the product of (x) the total number of Shares subject to such option immediately prior to the effective time multiplied by (y) the excess, if any, of the Cash Consideration over the applicable exercise price per Share under such option, and (B) one CVR for each Share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-028649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924322028649/doc4.xml","form_type":"4"}},{"id":2185626,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T20:19:43.000Z","date":"2022-08-15","kind":"other","acquired":false,"shares":21650,"price":10,"value":216500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the Merger Agreement and the Tender Offer Statement on Schedule TO filed by Ginger Merger Sub, Inc., these Shares were tendered and disposed of at the Acceptance Time in exchange for the right to receive the consideration per Share of (i) $10.00, payable to the holder thereof of cash, without interest but subject to reduction for any applicable withholding Taxes payable in respect thereof, and (ii) one CVR per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Merger Agreement and the Tender Offer Statement on Schedule TO filed by Ginger Merger Sub, Inc., these Shares were tendered and disposed of at the Acceptance Time in exchange for the right to receive the consideration per Share of (i) $10.00, payable to the holder thereof of cash, without interest but subject to reduction for any applicable withholding Taxes payable in respect thereof, and (ii) one CVR per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-028649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924322028649/doc4.xml","form_type":"4"}},{"id":2426659,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-25T21:30:56.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the grant date, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":6.4,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-004788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919122004788/doc4.xml","form_type":"4"}},{"id":2426658,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T21:30:56.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on the first anniversary of the award date, subject to continued service with RDUS through such date."}],"balance_after":21650,"source":{"system":"sec-edgar","filing":"0001209191-22-004788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919122004788/doc4.xml","form_type":"4"}},{"id":2456160,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-12-30T21:00:23.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-21-068108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000121390021068108/ownership.xml","form_type":"4/A","original_submission_date":"2021-12-28"}},{"id":2456159,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-30T21:00:23.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001213900-21-068108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000121390021068108/ownership.xml","form_type":"4/A","original_submission_date":"2021-12-28"}},{"id":2457861,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-12-28T21:00:26.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001213900-21-067727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000121390021067727/ownership.xml","form_type":"4"}},{"id":2457860,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-28T21:00:26.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer."}],"balance_after":52500,"source":{"system":"sec-edgar","filing":"0001213900-21-067727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000121390021067727/ownership.xml","form_type":"4"}},{"id":2570831,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (righ to buy)","published_at":"2021-09-14T19:26:06.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on June 16, 2021. This option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":0,"derivative":{"exercise_price":20.43,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-056049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056049/doc4.xml","form_type":"4"}},{"id":2570830,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:26:06.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on June 16, 2020.  The shares underlying this option became fully vested on the date of the Issuer's annual meeting of stockholders following the date of the grant, or June 16, 2021."}],"balance_after":0,"derivative":{"exercise_price":15.33,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-21-056049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056049/doc4.xml","form_type":"4"}},{"id":2570829,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:26:06.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on June 18, 2019. The shares underlying this option became fully vested on the date of the Issuer's annual meeting of stockholders following the date of the grant, or June 16, 2020."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-21-056049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056049/doc4.xml","form_type":"4"}},{"id":2570828,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-14T19:26:06.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":38135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Under the terms of the Tender Offer, Issuer outstanding stock options, if not vested became vested, and all Issuer stock options were converted into cash consideration at the amount of the difference between the exercise price of the option and the Tender Offer price of $38.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option became fully vested on March 9, 2021."}],"balance_after":0,"derivative":{"exercise_price":7.39,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":38135},"source":{"system":"sec-edgar","filing":"0001209191-21-056049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056049/doc4.xml","form_type":"4"}},{"id":2570827,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-14T19:26:06.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":29860,"price":38,"value":1134680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"As of September 14, 2021, Issuer was acquired in a cash tender by an indirect subsidiary of Sanofi, a French societe anonyme at a purchase price of $38.00 per share (the \"Tender Offer\"), as described more fully in the Schedule 14D-9 filed by the Issuer on August 16, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-056049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121056049/doc4.xml","form_type":"4"}},{"id":2666381,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T17:14:36.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":20.43,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919121040977/doc4.xml","form_type":"4"}},{"id":2839291,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-23T22:12:34.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the grant date, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":18.6,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-013308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919121013308/doc4.xml","form_type":"4"}},{"id":2839290,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T22:12:34.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on the first anniversary of the award date, subject to continued service with RDUS through such date."}],"balance_after":16150,"source":{"system":"sec-edgar","filing":"0001209191-21-013308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919121013308/doc4.xml","form_type":"4"}},{"id":2897701,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-25T22:02:01.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the first anniversary of the grant date or upon an earlier Change of Control (as defined in the registrant's 2018 Stock Option and Incentive Plan)."}],"balance_after":40000,"derivative":{"exercise_price":22,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-005108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919121005108/doc4.xml","form_type":"4"}},{"id":2907117,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-14T22:30:09.000Z","date":"2021-01-12","kind":"purchase","acquired":true,"shares":2500,"price":21,"value":52500.0,"ownership":{"direct":true},"balance_after":506226,"source":{"system":"sec-edgar","filing":"0000899243-21-002046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924321002046/doc4.xml","form_type":"4"}},{"id":2910960,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T22:35:07.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":433332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 433,332 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on January 7, 2022, with the remaining shares vesting in equal monthly installments over the following three years (36 months), subject to the reporting person's continued employment with the Issuer."}],"balance_after":433332,"derivative":{"exercise_price":21,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":433332},"source":{"system":"sec-edgar","filing":"0000899243-21-001365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000089924321001365/doc4.xml","form_type":"4"}},{"id":3109169,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-16T20:06:03.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":15.33,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-20-037123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919120037123/doc4.xml","form_type":"4"}},{"id":3241207,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-28T21:15:21.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":2750,"price":17.95,"value":49362.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":10650,"source":{"system":"sec-edgar","filing":"0001209191-20-013795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919120013795/doc4.xml","form_type":"4"}},{"id":3252938,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T22:58:14.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on February 20, 2021, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":19.96,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-012152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919120012152/doc4.xml","form_type":"4"}},{"id":3252937,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-24T22:58:14.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 20, 2021, subject to continued service with RDUS through such date."}],"balance_after":13400,"source":{"system":"sec-edgar","filing":"0001209191-20-012152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919120012152/doc4.xml","form_type":"4"}},{"id":3484277,"issuer":{"id":135439,"kind":"organization","name":"Translate Bio, Inc.","symbol":"TBIO"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-19T16:22:23.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full on the one year anniversary of the date of the award, or if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":10.2,"expiration_date":"2029-06-17","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001209191-19-038015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693415/000120919119038015/doc4.xml","form_type":"4"}},{"id":3552718,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-18T20:47:03.000Z","date":"2019-04-16","kind":"sale","acquired":false,"shares":2400,"price":22.22,"value":53328.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":7900,"source":{"system":"sec-edgar","filing":"0001209191-19-025254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919119025254/doc4.xml","form_type":"4"}},{"id":3632150,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-26T23:15:34.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on February 22, 2020, subject to continued service with RDUS through such date."}],"balance_after":10000,"derivative":{"exercise_price":19.18,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-013712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919119013712/doc4.xml","form_type":"4"}},{"id":3632149,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-26T23:15:34.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 22, 2020, subject to continued service with RDUS through such date."}],"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001209191-19-013712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919119013712/doc4.xml","form_type":"4"}},{"id":3660424,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-02-13T22:23:18.000Z","date":"2019-02-13","kind":"exercise","acquired":false,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on February 13, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001209191-19-009753","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919119009753/doc4.xml","form_type":"4"}},{"id":3660423,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-13T22:23:18.000Z","date":"2019-02-13","kind":"exercise","acquired":true,"shares":4800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock."}],"balance_after":4800,"source":{"system":"sec-edgar","filing":"0001209191-19-009753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919119009753/doc4.xml","form_type":"4"}},{"id":4054903,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-16T00:45:36.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full on February 13, 2019."}],"balance_after":4800,"derivative":{"underlying":"Common Stock","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001209191-18-010553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919118010553/doc4.xml","form_type":"4"}},{"id":4054902,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-16T00:45:36.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on February 13, 2019, subject to continued service to the Issuer through such date."}],"balance_after":8800,"derivative":{"exercise_price":37.83,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":8800},"source":{"system":"sec-edgar","filing":"0001209191-18-010553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919118010553/doc4.xml","form_type":"4"}},{"id":4431648,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":30680,"kind":"person","name":"Hughes Owen","position":1,"cik":"0001575933","reported_name":"Hughes Owen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-22T21:28:28.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on February 17, 2018, subject to continued service to the Issuer through such date."}],"balance_after":27500,"derivative":{"exercise_price":45.65,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-17-013262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1575933/000120919117013262/doc4.xml","form_type":"4"}}]}